Parametrica Management Ltd Buys Shares of 777 UnitedHealth Group Incorporated (NYSE:UNH)

Parametrica Management Ltd purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, Holdings Channel reports. The firm purchased 777 shares of the healthcare conglomerate’s stock, valued at approximately $393,000. UnitedHealth Group comprises about 0.5% of Parametrica Management Ltd’s holdings, making the stock its 24th largest position.

Other large investors also recently modified their holdings of the company. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth $25,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $30,000. Promus Capital LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter worth $32,000. RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group in the third quarter worth approximately $37,000. Finally, Pillar Financial Advisors LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at $40,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Down 0.6 %

UNH opened at $513.58 on Wednesday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm has a 50-day moving average price of $509.10 and a two-hundred day moving average price of $545.56. The stock has a market capitalization of $469.78 billion, a PE ratio of 33.13, a PEG ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the company earned $5.83 EPS. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.64%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Stephens lifted their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research report on Friday, January 10th. Piper Sandler dropped their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Finally, Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.